Optiscan Imaging

Optiscan Imaging Stock-Based Compensation

The Stock-Based Compensation (SBC) of Optiscan Imaging (OIL.AX) as of Oct 26, 2026 is 157,115.00 AUD. In the previous year, Stock-Based Compensation (SBC) was 229,401.00 AUD — a change of -31.51% (lower).

Stock-Based Compensation

157,115.00AUD

YoY

-31.51%

Last updated:

Stock-Based Compensation (SBC) of Optiscan Imaging is 2025 157,115.00 AUD. Stock-Based Compensation (SBC) of Optiscan Imaging was 2024 229,401.00 AUD. It decreases by -31.51% lower compared to the previous year.

The Optiscan Imaging Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2018
-9,874.00 AUD
Jan 1, 2019
561,248.00 AUD
Jan 1, 2020
293,898.00 AUD
Jan 1, 2021
173,801.00 AUD
Jan 1, 2022
376,590.00 AUD
Jan 1, 2023
233,842.00 AUD
Jan 1, 2024
229,401.00 AUD
Jan 1, 2025
157,115.00 AUD
The Optiscan Imaging Stock-Based Compensation history
YEARStock-Based CompensationYoY
157,115.00AUD-31.51%
229,401.00AUD-1.90%
233,842.00AUD-37.91%
376,590.00AUD+116.68%
173,801.00AUD-40.86%
293,898.00AUD-47.63%
561,248.00AUD-5,784.10%
-9,874.00AUD-101.15%
859,482.00AUD+830.66%
92,352.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Optiscan Imaging Stock analysis

What does Optiscan Imaging do? Optiscan Imaging Ltd is an Australian company specializing in the development and commercialization of advanced imaging technologies. The company was founded in 1994 and is headquartered in Notting Hill, a suburb of Melbourne. Optiscan was originally established as a spin-off company from Monash University to enable the commercial application of a groundbreaking technology called confocal microscopy. However, over the years, the company has expanded into other imaging technologies and now offers a wide range of products and services. Optiscan's business model involves developing and bringing to market innovative technologies that can be used in biomedical research and clinical diagnostics. The company works closely with research institutions and companies in various industries to develop customized imaging solutions. Optiscan offers a wide range of products, including confocal microscopes, multiphotonic microscopes, real-time imaging systems, and Raman spectrometers. These products are used in various application areas such as cancer research, neurobiology, cell biology, and materials science. Another important area for Optiscan is veterinary imaging. The company has developed a product line for veterinary medicine that is used by veterinarians and researchers around the world. Optiscan's imaging systems enable veterinarians to obtain precise and detailed images of animals to enable better diagnosis and treatment. Optiscan also operates a service department that offers customized imaging solutions to customers. The company provides services such as image processing, data analysis, and prototype development. Overall, Optiscan has become one of the leading providers of imaging technologies in Australia and globally over the past decades. The company has a long history of collaboration with leading research institutions and companies worldwide and remains committed to developing innovative solutions for the challenges of biomedicine and imaging. Optiscan Imaging is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optiscan Imaging stock

Stock-Based Compensation (SBC) of Optiscan Imaging is 157,115.00 AUD in 2025.

Stock-Based Compensation (SBC) of Optiscan Imaging changed from 229,401.00 AUD to 157,115.00 AUD, representing a -31.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Optiscan Imaging since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Optiscan Imaging historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Optiscan Imaging

All Key Metrics — Optiscan Imaging